Risperidone‑induced mania: An emergent complication of treatment
- 1*,
- 1,
- 2,
- 1
- 1Department of Psychiatry, Central Institute of Psychiatry, Ranchi, Jharkhand, India.
- 2Murshidabad Medical College and Hospital, Berhampore, West Bengal, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Anjana Rao Kavoor
Department of Psychiatry, Central Institute of Psychiatry, Ranchi, Jharkhand, India.
Copyright: © 2014 The Author(s). This is an open access article.
Published: Jan 1, 2014, Received: Dec 8, 2013, Accepted: Mar 2, 2014
Abstract
The occurrence of manic/hypomanic switch in patients being treated with risperidone has been reported by various authors, and they have described a variety of strategies for their management. In this report, we describe two cases of induction of elevated mood symptoms in patients treated with risperidone. We propose that the emergence of these symptoms may be a complication of treatment with this drug in susceptible individuals, of which the clinicians should be aware, mainly in those diagnosed with schizophrenia and bipolar disorder. We then discuss a few findings that might be useful in the management of such cases. We thereby also propose a mechanism for such an induction.
Keywords
Subject
Recommended articles
- Risperidone-Induced Adverse Drug Reactions and Role of DRD2 (−141 C Ins/Del) and 5HTR2C (−759 C>T) Genetic Polymorphisms in Patients with Schizophrenia
Charanraj Goud Alladi, Anbarasan Mohan, Deepak Gopal Shewade · Journal of Pharmacology and Pharmacotherapeutics
- Isolated sinus tachycardia following reinitiation of risperidone in a patient with suspected autonomic hypersensitivity
Melanie J Grubisha, Jessica L Brennan, Antoine Douaihy · Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and its Mutated Variants: Challenges and Future Directions
Mohammed Ali Bakkari, Gassem Ghoal, Fahad Y. Sabei
Jan 1, 2025
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026